Incyte Corp financial data

Symbol
INCY on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
1801 Augustine Cut Off, Wilmington, Delaware
State of incorporation
Delaware
Fiscal year end
December 31
Former names
INCYTE INC (to 3/28/2003), INCYTE GENOMICS INC (to 2/25/2003), INCYTE PHARMACEUTICALS INC (to 4/18/2000)
Latest financial report
10-Q - Q2 2024 - Jul 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 323 % -14.3%
Quick Ratio 5.58 % +45.3%
Debt-to-equity 34.9 % +11.7%
Return On Equity 2.1 % -74.4%
Return On Assets 1.56 % -75.2%
Operating Margin 21.6 % +43.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 193M shares -14.1%
Common Stock, Shares, Outstanding 192M shares -14.2%
Entity Public Float 11.7B USD -17.6%
Common Stock, Value, Issued 191K USD -14.4%
Weighted Average Number of Shares Outstanding, Basic 218M shares -2.27%
Weighted Average Number of Shares Outstanding, Diluted 218M shares -3.31%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.32B USD +22.1%
Revenue from Contract with Customer, Excluding Assessed Tax 3.86B USD +9.78%
Cost of Revenue 267M USD +11.9%
Research and Development Expense 2.39B USD +41.1%
Costs and Expenses 3.84B USD +24.5%
Operating Income (Loss) 15.7M USD -96.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 351M USD -37.1%
Income Tax Expense (Benefit) 254M USD +32.1%
Net Income (Loss) Attributable to Parent 97.3M USD -73.5%
Earnings Per Share, Basic 0.38 USD/shares -76.8%
Earnings Per Share, Diluted 0.36 USD/shares -77.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 987M USD -68.5%
Inventory, Net 101M USD +180%
Assets, Current 2.57B USD -39.8%
Deferred Income Tax Assets, Net 730M USD +37%
Property, Plant and Equipment, Net 762M USD +1.69%
Goodwill 156M USD 0%
Other Assets, Noncurrent 21.9M USD -30.9%
Assets 4.66B USD -24.9%
Accounts Payable, Current 148M USD -4.74%
Employee-related Liabilities, Current 114M USD +1.64%
Accrued Liabilities, Current 1.03B USD +27.6%
Liabilities, Current 1.34B USD +19.5%
Operating Lease, Liability, Noncurrent 14.3M USD +1.24%
Other Liabilities, Noncurrent 142M USD +1.64%
Liabilities 1.66B USD +13.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.42M USD -120%
Retained Earnings (Accumulated Deficit) -1.38B USD -551%
Stockholders' Equity Attributable to Parent 3B USD -36.8%
Liabilities and Equity 4.66B USD -24.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 219M USD
Net Cash Provided by (Used in) Financing Activities -12.4M USD -410%
Net Cash Provided by (Used in) Investing Activities -73.1M USD -156%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 192M shares -14.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 133M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 989M USD -68.4%
Deferred Tax Assets, Valuation Allowance 2.1B USD +344%
Deferred Tax Assets, Gross 2.77B USD +185%
Operating Lease, Liability 20M USD -10.5%
Payments to Acquire Property, Plant, and Equipment 48.7M USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 65.1M USD -84.5%
Lessee, Operating Lease, Liability, to be Paid 22.6M USD -10.6%
Property, Plant and Equipment, Gross 1.06B USD +7.19%
Operating Lease, Liability, Current 4.93M USD -30.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.41M USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.51M USD -28.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.67M USD -11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.89M USD +41.7%
Deferred Tax Assets, Operating Loss Carryforwards 326M USD +79.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 69.1M USD -5.33%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.9M USD +90.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 21.9M USD +14.2%
Deferred Tax Assets, Net of Valuation Allowance 672M USD +34.3%
Share-based Payment Arrangement, Expense 224M USD +8.93%
Interest Expense 2.51M USD +2.32%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%